Cargando…

11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism

OBJECTIVE: Differentiation of an adrenal from an ovarian source of hyperandrogenemia can be challenging. Recent studies have highlighted the importance of 11-oxygenated C19 steroids to the androgen pool in humans. The aim of this study was to confirm the origin of 11-oxygenated androgens in females...

Descripción completa

Detalles Bibliográficos
Autores principales:	Auer, Matthias K, Hawley, James M, Lottspeich, Christian, Bidlingmaier, Martin, Sappl, Andrea, Nowotny, Hanna F, Tschaidse, Lea, Treitl, Marcus, Reincke, Martin, Keevil, Brian G, Reisch, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716487/ https://www.ncbi.nlm.nih.gov/pubmed/36239921 http://dx.doi.org/10.1530/EJE-22-0518

Ejemplares similares

OR27-1 11-Oxygenated C19 Steroids Are the Predominant Androgens Responsible for Hyperandrogenemia in Cushing's Disease
por: Adaway, Jo, et al.
Publicado: (2022)

11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing’s disease
por: Nowotny, Hanna F, et al.
Publicado: (2022)

SAT282 Hypogonadism In Men With Congenital Adrenal Hyperplasia. A Retrospective Longitudinal Analysis With A Special Focus On Testicular Adrenal Rest Tumors And 11-oxygenated Androgens
por: Auer, Matthias K, et al.
Publicado: (2023)

Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia
por: Nowotny, Hanna Franziska, et al.
Publicado: (2021)

SAT303 High Frequency Of Stress Dose Adjustment And Adrenal Crisis In Adult Patients With Congenital Adrenal Hyperplasia
por: Tschaidse, Lea, et al.
Publicado: (2023)

Ectopic Prostate Tissue in the Uterine Cervix of a Female with Non-Classic Congenital Adrenal Hyperplasia—A Case Report
por: Tschaidse, Lea, et al.
Publicado: (2022)

MON-177 CAH-X Syndrome in a German Cohort of Patients with Congenital Adrenal Hyperplasia
por: Sappl, Andrea, et al.
Publicado: (2020)

SAT297 Major Immunophenotypic Abnormalities In Patients With Primary Adrenal Insufficiency Of Different Etiology
por: Nowotny, Hanna Franziska, et al.
Publicado: (2023)

Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
por: Nowotny, Hanna F., et al.
Publicado: (2023)

E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess
por: Zhang, Wei, et al.
Publicado: (2023)

Androgen-secreting adenoma – a possibility in hyperandrogenism differential diagnosis
por: Casal, Henar, et al.
Publicado: (2023)

Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism
por: Mansour, Nabeel, et al.
Publicado: (2023)

Androgen secreting steroid cell tumor of the ovary in a young lactating women with acute onset of severe hyperandrogenism: a case report and review of literature
por: Haji, Altaf Gauhar, et al.
Publicado: (2007)

The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
por: Turan, Mahfuz, et al.
Publicado: (2016)

Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome
por: Donbaloğlu, Zeynep, et al.
Publicado: (2022)

Thyroid Disorders and Movement Disorders—A Systematic Review
por: Schneider, Susanne A., et al.
Publicado: (2023)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism
por: Rajamani, Krishnakumar, et al.
Publicado: (2022)

Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia
por: Dubinski, Ilja, et al.
Publicado: (2023)

Androgen Excess Disorders in Women: The Severe Insulin-Resistant Hyperandrogenic Syndrome, HAIR-AN
por: Rager, Kristin M., et al.
Publicado: (2006)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary
por: Rezvanfar, Mohammad Amin, et al.
Publicado: (2014)

Are Psychosocial Consequences of Obesity and Hyperandrogenism Present in Adolescent Girls with Polycystic Ovary Syndrome?
por: Zachurzok, Agnieszka, et al.
Publicado: (2018)

Post Menopausal Hyperandrogenism: A Case of a Steroid Cell Tumor of the Ovary
por: Hassan Nelson, Lauren Juliette, et al.
Publicado: (2021)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome
por: Comim, Fabio V., et al.
Publicado: (2013)

Body Image and Quality of Life in Women with Congenital Adrenal Hyperplasia
por: Tschaidse, Lea, et al.
Publicado: (2022)

Attenuated expression of MTR in both prenatally androgenized mice and women with the hyperandrogenic phenotype of PCOS
por: Lei, Lei, et al.
Publicado: (2017)

Ovaries Secrete Male Hormone: VI. A Preliminary Note on the Possibilities of Androgen-secreting Ovaries to Assume an Adrenal Function
por: Hill, R. T.
Publicado: (1944)

Postmenopausal Hyperandrogenism
por: Lal, Rayhan A, et al.
Publicado: (2018)

Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis
por: Yang, Rui, et al.
Publicado: (2016)

Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
por: Guo, Zaixin, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia
por: van’t Westeinde, Annelies, et al.
Publicado: (2023)

Secretion of Androgen by the Sparrow Ovary Following Stimulation with Pregnant Mare Serum
por: Pfeiffer, Carroll A., et al.
Publicado: (1941)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
por: Li, Andi, et al.
Publicado: (2018)

Effect of “DXB-2030,” a Polyherbal Formulation, on Experimental Polycystic Ovary Syndrome Associated with Hyperandrogenism
por: Azeemuddin, Mohammed, et al.
Publicado: (2019)

Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2022)

THU643 Hyperandrogenism Caused By A Steroid Cell Tumor Of The Ovary In A Postmenopausal Woman
por: Mon Myint, Myat Su, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rvkk5vusftqf3721fai777llnh